Skip to content

To study the comparative effect of kumkuma ghrita and go-ghrita nasal drops in treatment of one side headache.

AN OPEN LABELLED RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF KUMKUMA GHRITA NASYA AND GO-GHRITA NASYA IN THE MANAGEMENT OF ARDHAVABHEDAKA WITH SPECIAL REFFERENCE TO MIGRAINE - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098626
Enrollment
70
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

PARUL INSTITUTE OF AYURVED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients will be enrolled in the study based on the diagnostic criteria for Ardhavabhedaka (migraine). 2.Patients between the age group of 16-60yrs, of either sex. 3.Patients who are fit for Nasya karma.

Exclusion criteria

Exclusion criteria: Other known case of any systemic disease (HTN, COPD etc) Patients with conditions such as brain tumors, meningitis, cervical spondylitis, encephalitis, referred pain, refractive errors, or glaucoma will not be enrolled in this study Contraindicated for nasal instillation Nasya karma

Design outcomes

Primary

MeasureTime frame
Relief from one sided headacheTimepoint: 14th days and 27th days

Secondary

MeasureTime frame
Reduced frequency of headache Increase gap of episodeTimepoint: 14th days and 27th days

Countries

India

Contacts

Public ContactDr Manjiri Keskar

Parul institute of ayurved

manjirikeskar@gmail.com9822606358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026